Erlotinib treatment after platinum-based therapy in elderly patients with non-small-cell lung cancer in routine clinical practice – results from the ElderTac study

por Brueckl, Wolfgang M., Achenbach, H. Jost, Ficker, Joachim H., Schuette, Wolfgang
Publicado 2018

Quantitative assessment of the asphericity of pretherapeutic FDG uptake as an independent predictor of outcome in NSCLC

por Apostolova, Ivayla, Rogasch, Julian, Buchert, Ralph, Wertzel, Heinz, Achenbach, H Jost, Schreiber, Jens, Riedel, Sandra, Furth, Christian, Lougovski, Alexandr, Schramm, Georg, Hofheinz, Frank, Amthauer, Holger, Steffen, Ingo G
Publicado 2014

Plasma-based longitudinal mutation monitoring as a potential predictor of disease progression in subjects with adenocarcinoma in advanced non-small cell lung cancer

por Jiang, John, Adams, Hans-Peter, Lange, Maria, Siemann, Sandra, Feldkamp, Mirjam, McNamara, Sylvie, Froehler, Sebastian, Yaung, Stephanie J., Yao, Lijing, Balasubramanyam, Aarthi, Tikoo, Nalin, Ju, Christine, Achenbach, H. Jost, Krügel, Rainer, Palma, John F.
Publicado 2020